Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Post by nemmybudesison Dec 17, 2019 8:00am
225 Views
Post# 30462530

Buffoonery

Buffoonery  See : https://seekingalpha.com/instablog/969166-stockmatusow/5385140-trillium-therapeutics-showing-signs-of-life-cd-47-spec-play

Trouble with TRIL is that a lot of the old management team, who were complicit in said buffoonery, are still in place.
<< Previous
Bullboard Posts
Next >>